Related Experiment Video
Updated: Aug 3, 2025
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.7K
EGFR endocytosis: more than meets the eye
Oncotarget
|April 10, 2023
Abstract:
Behind the scenes of signaling cascades initiated by activated receptors, endocytosis determines the fate of internalized proteins through degradation in lysosomes or recycling. Over the years, significant progress has been made in understanding the mechanisms of endocytosis and deregulation in disease states. Here we review the role of the EGF-SNX3-EGFR axis in breast cancers with an extended discussion on deregulated EGFR endocytosis in cancer.
Insights
Endocytosis regulates protein fate after receptor activation, impacting cancer. This review focuses on the EGF-SNX3-EGFR pathway and its role in deregulated epidermal growth factor receptor (EGFR) endocytosis in breast cancer.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Endocytosis is a critical cellular process regulating the fate of internalized proteins, influencing signaling cascades initiated by activated receptors.
- Mechanisms of endocytosis and its deregulation in disease states have been extensively studied, revealing its significance in various pathologies.
- The epidermal growth factor receptor (EGFR) pathway is a key player in cell growth and proliferation, and its dysregulation is implicated in numerous cancers.
Discussion:
- This review highlights the crucial role of the Epidermal Growth Factor (EGF)-Sorting Nexin 3 (SNX3)-Epidermal Growth Factor Receptor (EGFR) axis in the context of breast cancer.
- It provides an in-depth discussion on how deregulated EGFR endocytosis contributes to cancer progression and development.
- Understanding this axis offers insights into potential therapeutic strategies targeting EGFR trafficking in cancer.
Key Insights:
- The EGF-SNX3-EGFR axis is a critical determinant of EGFR fate, influencing downstream signaling and cellular responses.
- Aberrant endocytosis of EGFR, mediated by this axis, promotes uncontrolled cell growth and survival in breast cancer.
- Targeting specific components or mechanisms within this pathway could offer novel therapeutic avenues for breast cancer treatment.
Outlook:
- Further research into the intricate mechanisms of the EGF-SNX3-EGFR axis and its regulation in cancer is warranted.
- Exploring the potential of modulating EGFR endocytosis as a therapeutic strategy holds promise for improving breast cancer outcomes.
- Investigating the interplay between this axis and other cancer-related pathways may reveal synergistic therapeutic targets.
More Related Videos
Related Concept Videos
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
01:39Receptor-mediated Endocytosis
104.9K
Overview
104.9K
01:28The Early Endosome: Endocytosis of Transferrin
3.4K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.4K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
01:16Endocytosis
9.5K
Eukaryotic cells acquire nutrients for growth and proliferation. Nutrients and other molecules that require degradation are internalized from the extracellular space by a process called endocytosis. The term ‘endocytosis' was first coined by Christian de Duve in 1963.
Endocytosis always begins with the plasma membrane enclosing an incoming molecule to form a transport vesicle which, in some cases, can be coated with a protein called ‘clathrin.' Endocytosed material is either...
Endocytosis always begins with the plasma membrane enclosing an incoming molecule to form a transport vesicle which, in some cases, can be coated with a protein called ‘clathrin.' Endocytosed material is either...
9.5K
00:58Recycling Endosomes and Transcytosis
2.7K
The recycling endosome, also known as the endosomal recycling compartment (ERC), is a part of the slow-recycling process of the endocytic pathway. Molecules internalized through receptor-mediated endocytosis are either degraded in the lysosomes or are recycled to the plasma membrane through the fast- or slow-recycling route.
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
2.7K